Gainers
-
SELLAS Life Sciences Group, Inc. (NYSE: SLS) shares
jumped 139.7 percent to $8.270 after the company disclosed positive interim data from its Phase 2b NeuVax trial.
-
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA)
shares gained 24.2 percent to $13.69.
-
MediciNova, Inc. (NASDAQ: MNOV) surged 19.2
percent to $12.18.
-
Remark Holdings, Inc. (NASDAQ: MARK) shares rose
13.4 percent to $6.4404
-
Commvault Systems, Inc. (NASDAQ: CVLT) gained
11.6 percent to $63.85 after Elliott Management disclosed a 10.3 percent stake in Commvault and announced intent to nominate 4
candidates to the board.
-
CASI Pharmaceuticals, Inc. (NASDAQ: CASI) gained
10.6 percent to $4.61. CASI Pharma posted a Q4 loss of $0.08 per share.
-
BioLife Solutions, Inc. (NASDAQ: BLFS) shares
rose 10.4 percent to $5.64 after the company reported preliminary revenue for the three months ended March 31, 2018.
-
Empire Resorts, Inc. (NASDAQ: NYNY) gained 9.6
percent to $18.90.
-
NACCO Industries, Inc. (NYSE: NC) shares surged 9.1
percent to $35.85.
-
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) rose
7.2 percent to $10.969. Barclays initiated coverage on BioXcel Therapeutics with an Overweight rating.
-
Humana Inc. (NYSE: HUM) rose 5.5 percent to $283.64.
Walmart is reportedly in early stage acquisition talks with Humana.
Check out these big penny stock gainers and
losers
Losers
-
Alkermes plc (NASDAQ: ALKS) tumbled 20.5 percent
to $46.07 after the U.S. Food and Drug Administration said it won't review the company's therapy ALKS-5461. Alkermes, which
mostly focuses on treatments for central nervous system diseases, said in a press release it received a Refusal to File letter
from the FDA regarding its New Drug Application (NDA) for ALKS-5461.
-
IZEA, Inc. (NASDAQ: IZEA) dropped 19.4 percent to
$2.95 as the company disclosed that it will reschedule its Q4 earnings release.
-
SORL Auto Parts, Inc. (NASDAQ: SORL) declined
17.8 percent to $5.35 after the company reported downbeat earnings for its fourth quarter..
-
Longfin Corp. (NASDAQ: LFIN) shares slipped 17.6
percent to $14.22 after declining 48.80 percent on Thursday.
-
Ovid Therapeutics Inc. (NASDAQ: OVID) shares
declined 17.2 percent to $5.855.
-
Veritiv Corporation (NYSE: VRTV) fell 16.8 percent
to $32.60.
-
China Auto Logistics Inc. (NASDAQ: CALI) shares
fell 16.2 percent to $2.8899 after rising 1.17 percent on Thursday.
-
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)
declined 15.9 percent to $100.21.
-
LSC Communications, Inc. (NYSE: LKSD) shares fell
14.3 percent to $14.9526. Bank of America downgraded LSC Communications from Neutral to Underperform.
-
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI)
dropped 14 percent to $18.11 after gaining 2.33 percent on Thursday.
-
SYNNEX Corporation (NYSE: SNX) shares fell 13.7
percent to $102.17. SYNNEX posted upbeat earnings for its first quarter, but issued weak earnings outlook for the current
quarter.
-
VirTra, Inc. (NASDAQ: VTSI) fell 13.4 percent to
$5.4535.
-
Galectin Therapeutics, Inc. (NASDAQ: GALT) shares
dipped 13.3 percent to $4.11.
-
Vishay Precision Group, Inc. (NYSE: VPG) shares
declined 11.7 percent to $27.50.
-
Pfenex Inc. (NASDAQ: PFNX) shares dropped 11.7
percent to $5.30.
-
KemPharm, Inc. (NASDAQ: KMPH) shares declined
10.8 percent to $7.05. KemPharm posted a Q4 loss of $0.72 per share.
-
Fitbit, Inc. (NYSE: FIT) shares fell 9.6 percent to
$4.61. Morgan Stanley downgraded Fitbit from Equal-weight to Underweight.
-
Geron Corporation (NASDAQ: GERN) shares declined
8.5 percent to $3.89.
-
BIO-key International, Inc. (NASDAQ: BKYI)
dropped 7.4 percent to $2.00.
-
Snap Inc. (NYSE: SNAP) fell 7.2 percent to $14.7294
after slipping 0.50 percent on Thursday.
-
ICICI Bank Limited (NYSE: IBN) fell 6.7 percent to
$8.256 following probe reports by Indian Police.
-
Tesla, Inc. (NASDAQ: TSLA) fell 6.2 percent to
$249.65 after gaining 3.24 percent on Thursday.
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.